OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Islet Expression Levels of Prostaglandin E2 Synthetic Enzymes, But Not Prostaglandin EP3 Receptor, Are Positively Correlated with Markers of β-Cell Function and Mass in Nondiabetic Obesity
Nathan A. Truchan, Rachel J. Fenske, Harpreet Sandhu, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 4, pp. 1338-1348
Open Access | Times Cited: 17

Showing 17 citing articles:

Role of Oxylipins in the Inflammatory-Related Diseases NAFLD, Obesity, and Type 2 Diabetes
Mariya Misheva, Jethro S. Johnson, James McCullagh
Metabolites (2022) Vol. 12, Iss. 12, pp. 1238-1238
Open Access | Times Cited: 35

Effects of Arachidonic Acid and Its Metabolites on Functional Beta-Cell Mass
Karin J. Bosma, Cecilia E. Kaiser, Michelle E. Kimple, et al.
Metabolites (2022) Vol. 12, Iss. 4, pp. 342-342
Open Access | Times Cited: 30

Plasma Prostaglandin E2 Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation
Rachel J. Fenske, Alicia Weeks, Michael Daniels, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1234-1234
Open Access | Times Cited: 15

Metformin Monotherapy Alters the Human Plasma Lipidome Independent of Clinical Markers of Glycemic Control and Cardiovascular Disease Risk in a Type 2 Diabetes Clinical Cohort
Benjamin Wancewicz, Yanlong Zhu, Rachel J. Fenske, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 386, Iss. 2, pp. 169-180
Open Access | Times Cited: 6

What the BTBR/J mouse has taught us about diabetes and diabetic complications
Mark P. Keller, Kelly L. Hudkins, Anath Shalev, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107036-107036
Open Access | Times Cited: 5

Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance
Jaclyn A. Wisinski, Austin Reuter, Darby C. Peter, et al.
AJP Endocrinology and Metabolism (2021) Vol. 321, Iss. 4, pp. E479-E489
Open Access | Times Cited: 8

The Kv2.2 channel mediates the inhibition of Prostaglandin E2 on glucose-stimulated insulin secretion in pancreatic β-cells
Chengfang Pan, Ying Liu, Liangya Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

The prostaglandin E2 EP3 receptor has disparate effects on islet insulin secretion and content in β-cells in a high-fat diet-induced mouse model of obesity
Joshua C. Neuman, Austin Reuter, Kathryn A. Carbajal, et al.
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 5, pp. E567-E576
Closed Access

Prostaglandin analogues signal detection by data mining in the FDA Adverse Event Reporting System database
Homero Contreras-Salinas, María Soledad Romero-López, Oscar Olvera‐Montaño, et al.
BMJ Open Ophthalmology (2024) Vol. 9, Iss. 1, pp. e001764-e001764
Open Access

Effect of Roux-en-Y Gastric Bypass on circulating oxylipin profile in women with obesity and type 2 diabetes
Daiane Cavalari-Mancuzo, Natasha Mendonça Machado, Juliana Teppedino, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2023) Vol. 200, pp. 102605-102605
Closed Access | Times Cited: 1

Prostaglandin analogs signal detection by data mining in the FDA Adverse Event Reporting System database.
Homero Contreras-Salinas, María Soledad Romero-López, Oscar Olvera‐Montaño, et al.
Research Square (Research Square) (2024)
Open Access

Gαz-independent and -dependent Improvements With EPA Supplementation on the Early Type 1 Diabetes Phenotype of NOD Mice
Rachel J. Fenske, Haley Wienkes, Darby C. Peter, et al.
Journal of the Endocrine Society (2024) Vol. 8, Iss. 7
Open Access

Prostaglandin EP3 Receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance
Jaclyn A. Wisinski, Austin Reuter, Darby C. Peter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 1

Page 1

Scroll to top